156 related articles for article (PubMed ID: 23376353)
1. cRGD-functionalized polymeric magnetic nanoparticles as a dual-drug delivery system for safe targeted cancer therapy.
Shen JM; Gao FY; Yin T; Zhang HX; Ma M; Yang YJ; Yue F
Pharmacol Res; 2013 Apr; 70(1):102-15. PubMed ID: 23376353
[TBL] [Abstract][Full Text] [Related]
2. Biotin-Conjugated Multilayer Poly [D,L-lactide-co-glycolide]-Lecithin-Polyethylene Glycol Nanoparticles for Targeted Delivery of Doxorubicin.
Dai Y; Xing H; Song F; Yang Y; Qiu Z; Lu X; Liu Q; Ren S; Chen X; Li N
J Pharm Sci; 2016 Sep; 105(9):2949-2958. PubMed ID: 27209461
[TBL] [Abstract][Full Text] [Related]
3. Construction and evaluation of Fe₃O₄-based PLGA nanoparticles carrying rtPA used in the detection of thrombosis and in targeted thrombolysis.
Zhou J; Guo D; Zhang Y; Wu W; Ran H; Wang Z
ACS Appl Mater Interfaces; 2014 Apr; 6(8):5566-76. PubMed ID: 24693875
[TBL] [Abstract][Full Text] [Related]
4. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
[TBL] [Abstract][Full Text] [Related]
5. Polymeric-gold nanohybrids for combined imaging and cancer therapy.
Topete A; Alatorre-Meda M; Villar-Alvarez EM; Carregal-Romero S; Barbosa S; Parak WJ; Taboada P; Mosquera V
Adv Healthc Mater; 2014 Aug; 3(8):1309-25. PubMed ID: 24764284
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo evaluation of anti-nucleolin-targeted magnetic PLGA nanoparticles loaded with doxorubicin as a theranostic agent for enhanced targeted cancer imaging and therapy.
Mosafer J; Abnous K; Tafaghodi M; Mokhtarzadeh A; Ramezani M
Eur J Pharm Biopharm; 2017 Apr; 113():60-74. PubMed ID: 28012991
[TBL] [Abstract][Full Text] [Related]
7. cRGD-functionalized reduction-sensitive shell-sheddable biodegradable micelles mediate enhanced doxorubicin delivery to human glioma xenografts in vivo.
Zhu Y; Zhang J; Meng F; Deng C; Cheng R; Feijen J; Zhong Z
J Control Release; 2016 Jul; 233():29-38. PubMed ID: 27178807
[TBL] [Abstract][Full Text] [Related]
8. Study and evaluation of nucleolin-targeted delivery of magnetic PLGA-PEG nanospheres loaded with doxorubicin to C6 glioma cells compared with low nucleolin-expressing L929 cells.
Mosafer J; Teymouri M; Abnous K; Tafaghodi M; Ramezani M
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():123-133. PubMed ID: 28024568
[TBL] [Abstract][Full Text] [Related]
9. Low-molecular-weight protamine-modified PLGA nanoparticles for overcoming drug-resistant breast cancer.
Wang H; Zhao Y; Wang H; Gong J; He H; Shin MC; Yang VC; Huang Y
J Control Release; 2014 Oct; 192():47-56. PubMed ID: 25003794
[TBL] [Abstract][Full Text] [Related]
10. Surface modification of doxorubicin-loaded nanoparticles based on polydopamine with pH-sensitive property for tumor targeting therapy.
Bi D; Zhao L; Yu R; Li H; Guo Y; Wang X; Han M
Drug Deliv; 2018 Nov; 25(1):564-575. PubMed ID: 29457518
[TBL] [Abstract][Full Text] [Related]
11. Poly aspartic acid peptide-linked PLGA based nanoscale particles: potential for bone-targeting drug delivery applications.
Jiang T; Yu X; Carbone EJ; Nelson C; Kan HM; Lo KW
Int J Pharm; 2014 Nov; 475(1-2):547-57. PubMed ID: 25194353
[TBL] [Abstract][Full Text] [Related]
12. Integrin-targeting thermally cross-linked superparamagnetic iron oxide nanoparticles for combined cancer imaging and drug delivery.
Yu MK; Park J; Jeong YY; Moon WK; Jon S
Nanotechnology; 2010 Oct; 21(41):415102. PubMed ID: 20852354
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterization of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles as a sustained-release anticancer drug delivery system.
Amjadi I; Rabiee M; Hosseini MS; Mozafari M
Appl Biochem Biotechnol; 2012 Nov; 168(6):1434-47. PubMed ID: 22976852
[TBL] [Abstract][Full Text] [Related]
14. Folate-targeting magnetic core-shell nanocarriers for selective drug release and imaging.
Wang H; Wang S; Liao Z; Zhao P; Su W; Niu R; Chang J
Int J Pharm; 2012 Jul; 430(1-2):342-9. PubMed ID: 22525087
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization novel polymer-coated magnetic nanoparticles as carriers for doxorubicin.
Li F; Sun J; Zhu H; Wen X; Lin C; Shi D
Colloids Surf B Biointerfaces; 2011 Nov; 88(1):58-62. PubMed ID: 21764271
[TBL] [Abstract][Full Text] [Related]
16. cRGD-decorated biodegradable polytyrosine nanoparticles for robust encapsulation and targeted delivery of doxorubicin to colorectal cancer in vivo.
Gu X; Wei Y; Fan Q; Sun H; Cheng R; Zhong Z; Deng C
J Control Release; 2019 May; 301():110-118. PubMed ID: 30898610
[TBL] [Abstract][Full Text] [Related]
17. A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: preparation, in vitro and in vivo evaluation.
Li Q; Lv S; Tang Z; Liu M; Zhang D; Yang Y; Chen X
Int J Pharm; 2014 Aug; 471(1-2):412-20. PubMed ID: 24905776
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin loaded magnetic gold nanoparticles for in vivo targeted drug delivery.
Elbialy NS; Fathy MM; Khalil WM
Int J Pharm; 2015 Jul; 490(1-2):190-9. PubMed ID: 25997662
[TBL] [Abstract][Full Text] [Related]
19. Dual targeted polymeric nanoparticles based on tumor endothelium and tumor cells for enhanced antitumor drug delivery.
Gupta M; Chashoo G; Sharma PR; Saxena AK; Gupta PN; Agrawal GP; Vyas SP
Mol Pharm; 2014 Mar; 11(3):697-715. PubMed ID: 24512060
[TBL] [Abstract][Full Text] [Related]
20. PLGA/polymeric liposome for targeted drug and gene co-delivery.
Wang H; Zhao P; Su W; Wang S; Liao Z; Niu R; Chang J
Biomaterials; 2010 Nov; 31(33):8741-8. PubMed ID: 20727587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]